We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

034730:KRXSK Inc. Analysis

Data as of 2026-03-14 - not real-time

₩331,000.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

SK Inc. is trading at KRW 331,000, comfortably below its 20‑day SMA of 361,775 but just above the 50‑day SMA of 321,210, indicating short‑term weakness within a broader bullish trend. The MACD histogram is negative and the signal line is bearish, while the RSI sits at 46, suggesting neutral momentum. Volatility is elevated at 87% over the past 30 days, yet the beta of 0.58 points to lower market‑wide sensitivity. The current price exceeds the DCF‑derived fair value of roughly KRW 208,000, flagging an overvaluation despite a forward P/E of 5.2, which is well below the industry average of 29.
Fundamentally, the company delivers a 2.42% dividend yield, but the payout ratio of 236% is unsustainable, and free cash flow is negative. A debt‑to‑equity ratio over 100% and thin operating margins (gross 7.5%, operating 2.1%) raise concerns about financial resilience, while ROE sits at a modest 4.4%. These mixed signals suggest caution, especially given the high volatility and leverage, even as the stock shows upside potential toward analyst target prices.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 20‑day SMA indicating short‑term weakness
  • Bearish MACD histogram and signal line
  • Neutral RSI around 46 with high recent volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Price above 50‑day SMA supporting a medium‑term uptrend
  • Increasing volume trend signaling growing investor interest
  • Upside potential of ~26% to analyst median target price

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High dividend yield but unsustainable payout ratio
  • Elevated debt‑to‑equity and negative free cash flow
  • Low profitability margins and modest ROE

Key Metrics & Analysis

Financial Health

Revenue Growth3.30%
Profit Margin1.38%
P/E Ratio5.2
ROE4.45%
ROA0.12%
Debt/Equity101.11
Op. Cash Flow₩6356.2B
Free Cash Flow₩-1637972312064
Industry P/E29.1

Technical Analysis

TrendBullish
RSI46.3
Support₩317,000.00
Resistance₩424,000.00
MA 20₩361,775.00
MA 50₩321,210.00
MA 200₩242,712.00
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value₩208,235.15
Target Price₩417,416.66
Upside/Downside26.11%
GradeOvervalued
TypeValue
Dividend Yield2.42%

Risk Assessment

Beta0.58
Volatility87.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.